Zomedica Corp. (AMEX: ZOM) on May 19, 2023, started off the session at the price of $0.20, soaring 2.19% from the previous trading day. During the day, the shares moved up to $0.21 and dropped to $0.20 before settling in for the closing price of $0.20. Within the past 52 weeks, ZOM’s price has moved between $0.15 and $0.41.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 9.70%. With a float of $965.42 million, this company’s outstanding shares have now reached $979.95 million.
The firm has a total of 85 workers. Let’s measure their productivity. In terms of profitability, gross margin is +50.77, operating margin of -115.81, and the pretax margin is -102.38.
Zomedica Corp. (ZOM) Insider Activity
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Zomedica Corp. is 1.33%, while institutional ownership is 9.70%.
Zomedica Corp. (ZOM) Earnings and Forecasts
As on 3/30/2023, Multinational firm has announced its last quarter scores, in which it reported -$0.01 earnings per share (EPS) for the period falling under the consensus outlook (set at $0) by -$0.01. This company achieved a net margin of -89.88 while generating a return on equity of -6.32. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 9.70% per share during the next fiscal year.
Zomedica Corp. (AMEX: ZOM) Trading Performance Indicators
Zomedica Corp. (ZOM) is currently performing well based on its current performance indicators. A quick ratio of 14.80 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.50.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.02, a number that is poised to hit 0.00 in the next quarter and is forecasted to reach 0.00 in one year’s time.
Technical Analysis of Zomedica Corp. (ZOM)
Analysing the last 5-days average volume posted by the [Zomedica Corp., ZOM], we can find that recorded value of 3.59 million was lower than the volume posted last year of 7.15 million. As of the previous 9 days, the stock’s Stochastic %D was 27.25%. Additionally, its Average True Range was 0.01.
During the past 100 days, Zomedica Corp.’s (ZOM) raw stochastic average was set at 29.73%, which indicates a significant decrease from 42.31% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 52.22% in the past 14 days, which was lower than the 76.11% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2102, while its 200-day Moving Average is $0.2306. Now, the first resistance to watch is $0.2070. This is followed by the second major resistance level at $0.2090. The third major resistance level sits at $0.2130. If the price goes on to break the first support level at $0.2010, it is likely to go to the next support level at $0.1970. Should the price break the second support level, the third support level stands at $0.1950.
Zomedica Corp. (AMEX: ZOM) Key Stats
Market capitalization of the company is 196.60 million based on 979,950K outstanding shares. Right now, sales total 18,930 K and income totals -17,020 K. The company made 5,480 K in profit during its latest quarter, and -6,390 K in sales during its previous quarter.
